Htl Announces Its Incubator's Equity Investment In Gelmedix, An Early-Stage Biotech Aiming At Revolutionizing Ocular And Regenerative Therapies
Round Type
Venture
CambridgeBiotechnologyDescription
HTL Biotechnology, a pioneer and world leader in the development and production of innovative pharmaceutical grade biopolymers, today announced its incubator's first equity investment in GelMEDIX Inc., an early-stage biotechnology company committed to developing the next generation of ocular and regenerative therapies.
Quick answer
GelMEDIX raised an undisclosed amount in a funding round, dated March 10, 2022. GelMEDIX is based in Cambridge, Massachusetts, United States.
- How much did GelMEDIX raise?
- GelMEDIX raised an undisclosed amount in a funding round on March 10, 2022.
- What does GelMEDIX do?
- GelMEDIX Inc. is an early-stage biotechnology company leveraging its hydrogel platform to develop ocular and regenerative therapies that can restore vision.
- Where is GelMEDIX based and how big is it?
- GelMEDIX is based in Cambridge, Massachusetts, United States. Fundz records about 10 employees.
- Who are the decision-makers at GelMEDIX?
- Fundz holds 1 contact at GelMEDIX, including the Scientific Co-Founder. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as GelMEDIX that raised within 45 days of this round, from Fundz verified event records.
- Amydis, Inc. raised $5.7M on April 22, 2022.
- CytoDyn raised $1.9M (Seed) on April 22, 2022.
- Aurion Biotech raised $55M on April 21, 2022.
- Codexis raised an undisclosed amount (Corporate Round) on April 21, 2022.
- Dianthus Therapeutics, Inc. raised $100M on April 21, 2022.
- ENDRA Life Sciences raised $8.7M (Post-IPO Equity) on April 21, 2022.
Who to call at GelMEDIX, and when
A new round usually means GelMEDIX is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day GelMEDIX raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at GelMEDIX, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at GelMEDIX. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment GelMEDIX raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
GelMEDIX raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.